Web Results

Wolfe v. North Carolina - Wikipedia

en.wikipedia.org/wiki/Wolfe_v._North_Carolina

Wolfe v. North Carolina 364 U.S. 177 (1960), is a 1960 United States Supreme Court case in ... Wolfe et al v. North Carolina. Seal of the United States Supreme Court.svg. Supreme Court of the United...

Thalidomide in induction treatment increases the very good partial ...

www.ncbi.nlm.nih.gov/pubmed/18166796

Lokhorst HM(1), Schmidt-Wolf I, Sonneveld P, van der Holt B, Martin H, Barge R ... patients randomized to VAD (vincristine, adriamycin, dexamethasone, 72% vs.

Daratumumab and its potential in the treatment of multiple myeloma ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4480519/

Daratumumab is dosed at 16 mg/kg in this study [Plesner et al. ... [PubMed]; Chillemi A., Zaccarello G., Quarona V., Ferracin M., Ghimenti C., Massaia M., et al . ... Gangatharan S., Carney D., Prince H., Wolf M., Januszewicz E., Ritchie D., et al. .... Plesner T., Arkenau H., Lokhorst H., Gimsing P., Krejcik J., Lemech C., et al.

A randomized phase 3 study on the effect of thalidomide combined ...

www.bloodjournal.org/content/115/6/1113

Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Edo Vellenga, ..... Patients randomized to thalidomide had a significantly prolonged EFScens (34 months vs 22 months; HR = 0.60 ..... Lokhorst HM,; Schmidt-Wolf I,; Sonneveld P,; et al.

Wolfe v. Tobacco Express, II, Inc. et al, No. 1:2013cv00104 ...

law.justia.com/cases/federal/district-courts/mississippi/mssdce/1:2013cv00104/81655/136/

Wolfe v. Tobacco Express, II, Inc. et al, No. 1:2013cv00104 - Document 136 (S.D. Miss. 2014) case opinion from the Southern District of Mississippi U.S. Federal ...

Wolfe v. Grange Indemn. Ins. Co. :: 2011 :: Ohio Court of Appeals ...

law.justia.com/cases/ohio/fifth-district-court-of-appeals/2011/2010ca00339.html

Wolfe v. Grange Indemn. Ins. Co. - 2011-Ohio-6122.

Bortezomib Induction and Maintenance Treatment in Patients With ...

ascopubs.org/doi/abs/10.1200/jco.2011.39.6820

Ingo G.H. Schmidt-Wolf ... Henk M. Lokhorst ... response (CR), including near CR, was superior after PAD induction (15% v 31%; P < .001) and bortezomib maintenance (34% v 49%; P < .001). ... Pieter Sonneveld et al., J Clin Oncol , 2012.

Leukemia - Monoclonal antibodies in the treatment of multiple ...

www.nature.com/leu/journal/v30/n3/full/leu2015223a.html

Oct 9, 2015 ... Median PFS was also longer in the high-dose cohort (23 vs 14.9 ...... Plesner T, Arkenau HT, Lokhorst HM, Gimsing P, Krejcik J, Lemech C et al. ..... Chanan- Khan A, Wolf JL, Garcia J, Gharibo M, Jagannath S, Manfredi D et al.

Moving Beyond Autologous Transplantation in ... - City of Hope

www.cityofhope.org/doc/1430440207273-wcc_074206.pdf&blobheadername1=Content-Disposition&blobheadername2=Content-Type&blobheadername3=MDT-Type&blobheadervalue1=attachment;filename=Briskin-Center---Moving-Beyond-Autologous-Transplantation.pdf&blobheadervalue2=application/x-download&blobheadervalue3=abinary%3B charset%3DUTF-8&blobnocache=true

(V-DTPACE) consolidation and then maintenance.10 The role of maintenance in these .... In the study by Roussel et al,16 the outcomes of patients who were ...

Standard PDF - Wiley Online Library

onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2012.09188.x/pdf

Jun 19, 2012 ... et al, 2008a; Spencer et al, 2009; Lokhorst et al, 2011; Mor- gan et al, 2012). This benefit is ..... pared with a historical control group of patients (72% vs. 51%). ..... Sonneveld, P., Scmidt-Wolf, I., van der Holt, B. & el Jarari, L.